David Amsellem
Stock Analyst at Piper Sandler
(4.84)
# 433
Out of 5,078 analysts
885
Total ratings
58.3%
Success rate
13.8%
Average return
Main Sectors:
Stocks Rated by David Amsellem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 13,664 | ILA 12,320 | +10.91% | 2 | Oct 23, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $303 | $285.64 | +6.08% | 29 | Oct 20, 2026 | |
| AMGN Amgen | Reiterated: Buy | $457 | $439.26 | +4.04% | 56 | Oct 20, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $65 | $43.63 | +48.98% | 43 | Oct 19, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $165 | $85.86 | +92.17% | 36 | Oct 19, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $82 | $61.48 | +33.38% | 21 | Oct 13, 2026 | |
| BIIB Biogen | Reiterated: Buy | $245 | $250.69 | -2.27% | 34 | Oct 12, 2026 | |
| VTRS Viatris | Reiterated: Hold | $13 | $18.00 | -27.78% | 26 | Oct 12, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $210 | $142.70 | +47.16% | 45 | Oct 9, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $214.00 | +44.86% | 71 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $258 | $145.04 | +77.88% | 28 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $10.20 | -21.57% | 15 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $35.67 | +110.26% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $17.00 | +182.35% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $20 | $25.14 | -20.45% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $43 | $22.96 | +87.28% | 46 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $40.70 | +62.16% | 70 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $20.38 | -16.58% | 42 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $59 | $34.47 | +71.16% | 14 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.00 | +100.00% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.08 | +78.57% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5 → $14 | $13.75 | +1.82% | 18 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $111 | $72.61 | +52.87% | 4 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $36.13 | +27.32% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $9 | $9.60 | n/a | 19 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $36.42 | n/a | 39 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4.20 | $9.03 | n/a | 64 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $3.46 | n/a | 9 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $12 | $0.94 | n/a | 12 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $17 | $1.00 | n/a | 29 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.0067 | n/a | 7 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $3 | $19.27 | n/a | 5 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $175 | $0.000001 | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $30.03 | n/a | 1 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.08 | n/a | 10 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0004 | n/a | 1 | Nov 11, 2013 |
Teva Pharmaceutical Industries Limited
Oct 23, 2026
Reiterated: Buy
Price Target: ILA 13,664
Current: ILA 12,320
Upside: +10.91%
AbbVie
Oct 20, 2026
Reiterated: Buy
Price Target: $303
Current: $285.64
Upside: +6.08%
Amgen
Oct 20, 2026
Reiterated: Buy
Price Target: $457
Current: $439.26
Upside: +4.04%
Alkermes
Oct 19, 2026
Reiterated: Buy
Price Target: $65
Current: $43.63
Upside: +48.98%
Corcept Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $165
Current: $85.86
Upside: +92.17%
Bristol-Myers Squibb Company
Oct 13, 2026
Reiterated: Buy
Price Target: $82
Current: $61.48
Upside: +33.38%
Biogen
Oct 12, 2026
Reiterated: Buy
Price Target: $245
Current: $250.69
Upside: -2.27%
Viatris
Oct 12, 2026
Reiterated: Hold
Price Target: $13
Current: $18.00
Upside: -27.78%
Neurocrine Biosciences
Oct 9, 2026
Reiterated: Buy
Price Target: $210
Current: $142.70
Upside: +47.16%
Jazz Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: $310
Current: $214.00
Upside: +44.86%
Sep 18, 2026
Reiterated: Buy
Price Target: $258
Current: $145.04
Upside: +77.88%
Sep 10, 2026
Reiterated: Hold
Price Target: $8
Current: $10.20
Upside: -21.57%
Aug 17, 2026
Reiterated: Buy
Price Target: $75
Current: $35.67
Upside: +110.26%
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $17.00
Upside: +182.35%
Aug 7, 2026
Reiterated: Hold
Price Target: $21 → $20
Current: $25.14
Upside: -20.45%
Aug 7, 2026
Reiterated: Hold
Price Target: $44 → $43
Current: $22.96
Upside: +87.28%
Jul 27, 2026
Reiterated: Buy
Price Target: $66
Current: $40.70
Upside: +62.16%
Jul 20, 2026
Reiterated: Buy
Price Target: $17
Current: $20.38
Upside: -16.58%
May 22, 2026
Reiterated: Buy
Price Target: $54 → $59
Current: $34.47
Upside: +71.16%
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $10.08
Upside: +78.57%
Apr 28, 2026
Upgraded: Hold
Price Target: $5 → $14
Current: $13.75
Upside: +1.82%
Apr 23, 2026
Reiterated: Buy
Price Target: $94 → $111
Current: $72.61
Upside: +52.87%
Apr 22, 2026
Reiterated: Buy
Price Target: $48 → $46
Current: $36.13
Upside: +27.32%
Mar 21, 2025
Downgraded: Hold
Price Target: $15 → $9
Current: $9.60
Upside: n/a
Nov 7, 2024
Reiterated: Hold
Price Target: $11 → $12
Current: $36.42
Upside: n/a
Oct 31, 2024
Reiterated: Sell
Price Target: $4.20
Current: $9.03
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $21 → $18
Current: $3.46
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $1 → $12
Current: $0.94
Upside: n/a
Aug 9, 2023
Downgraded: Sell
Price Target: $26 → $17
Current: $1.00
Upside: n/a
May 25, 2022
Reiterated: Buy
Price Target: $2
Current: $0.0067
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $20 → $3
Current: $19.27
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $6 → $175
Current: $0.000001
Upside: n/a
Jan 23, 2019
Upgraded: Hold
Price Target: n/a
Current: $30.03
Upside: n/a
Oct 12, 2017
Reiterated: Hold
Price Target: $3 → $2
Current: $1.08
Upside: n/a
Nov 11, 2013
Initiated Coverage: Buy
Price Target: $6
Current: $0.0004
Upside: n/a